Year-over-year, this metric grew by 983.3%, from -$408.00K to $3.60M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 13.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $219.00K | -$8.94M | $0.00 | $338.00K | $175.00K | $2.00M | $485.00K | $855.00K | $242.00K | $113.00K | $62.00K | $5.95M | $1.39M | $2.92M | $6.96M | -$408.00K | -$31.00K | $12.97M | $0.00 | $3.60M |
| QoQ Change | — | <-999% | +100.0% | — | -48.2% | >999% | -75.8% | +76.3% | -71.7% | -53.3% | -45.1% | >999% | -76.6% | +109.4% | +138.4% | -105.9% | +92.4% | >999% | -100.0% | — |
| YoY Change | — | — | — | — | -20.1% | +122.4% | — | +153.0% | +38.3% | -94.3% | -87.2% | +595.9% | +476.0% | >999% | >999% | -106.9% | -102.2% | +344.3% | -100.0% | +983.3% |